Upon validation of the target, primary assays aimed at identifying potential hits are developed. High throughput compound screening assays against the target of interest can lead to identification of initial hit compounds.
Those initial hits can be re-tested to validate their on-target activity. Finally, hits or hit series are ranked to select the most promising for the hit-to-lead phase.